Skip to main content
. 2023 Sep 18;6(9):e2333533. doi: 10.1001/jamanetworkopen.2023.33533

Figure 3. Kaplan-Meier Estimates of Progression-Free Survival From Randomization According to Mitogen-Activated Protein Kinase (MAPK) Pathway Activation (Intent-to-Treat Population).

Figure 3.

Shaded areas indicate 95% CIs.